Rep. Angie Craig Introduces Bill Ensuring Equitable COVID-19 Vaccine Distribution

October 9, 2020
Press Release

Today, U.S. Rep Angie Craig announced the introduction of new legislation aimed to ensure that an eventual COVID-19 vaccine is equitably allocated and distributed. The COVID-19 Vaccine Fairness Act would direct the Administration to develop a plan to provide states with the resources and direction needed to effectively administer the vaccine. A thorough and transparent strategy is needed to make sure no American is left behind. Rep. Craig has repeatedly called for national testing and supply chain strategies and this proposal is a continuation of her efforts to combat the spread of COVID-19. 

“A coordinated strategy between the federal government and states is critical to a successful and fair vaccine distribution,” said Rep. Craig. “As COVID-19 vaccine development progresses, the Administration must adopt a transparent plan that includes regular public updates to ensure that the vaccine is equitably distributed. The legislation I’ve put forward will require the Administration to be prepared with a detailed, transparent plan for vaccine distribution.” 

The COVID-19 Vaccine Fairness Act would direct the Department of Health and Human Services to provide weekly updates on the Administration’s efforts to ensure a transparent and equitable vaccine distribution process, including:

  • The number of the vaccines distributed and administered
  • Measures to ensure the vaccine reaches those groups particularly at risk for complications and transmission in accordance with the National Academies of Sciences, Engineering, and Medicine
  • Any bottlenecks in the supply chain, including obstacles reaching state, local, territorial, and tribal health departments, high-risk facilities such as long-term care facilities, and tracking   
  • Progress reports on outreach to the public about vaccine availability, safety, benefits, and contraindications
  • Efforts to update health care providers and facilities on their responsibilities regarding vaccine tracking and adverse event monitoring